• 제목/요약/키워드: Dosage forms

검색결과 160건 처리시간 0.018초

급성기 교통사고 상해 환자의 한약 복용에 관한 인식 조사 (A Survey on Acute Traffic Injury Patient's Perception on Korean Herbal Medicine)

  • 김수연;오승주;황규현;진은석;염선규;김동우;김석우;진소리;박무진;김은송;이현석
    • 한방재활의학과학회지
    • /
    • 제30권4호
    • /
    • pp.165-178
    • /
    • 2020
  • Objectives This survey study is designed to check the awareness and satisfaction of Korean herbal medicine in patients suffering from acute traffic accidents. Methods From May 1 to 20, 2020, patients who visited the hospital within 7 days after the accident and received prescription of Korean herbal medicine for the first-time symptoms were selected. Survey was conducted 10 days after the first visit to confirm the perception of Korean herbal medicine and expected to be used as a prior study to improve the quality of Korean medicine led by Korean herbal medicine. Results Most patients answered that they were aware of the prescribed Korean herbal medicine's dosage and treatment effects. 65% of the patients said they would like to receive other forms of prescription if possible. Most patients answered that portability is convenient and tastes better than normal. 48% of the respondents said that it was the first to time to take Korean herbal medicine, and 68% said that they were willing to take the Korean herbal medicine later. At the time of the first visit, the health condition assessed using EuroQol visual analogue scale (EQ-VAS) was 46.84, but 10 days after the treatment began, it increased significantly to 61.93. Conclusions The improvement of symptoms and high satisfaction with Korean medicine medical services contributed to the patient's willingness to visit the Korean medicine hospital again and to respond that they were willing to take further medication. EQ-VAS elevation suggests that overall patients' subjective health conditions have improved since treatment.

고시 수재 의약품 중 피라세탐 정 및 브롬화수소산페노테롤 정의 용출시험법 개발 (Development of Dissolution Testing Method for Piracetam Tablets and Fenoterol Hydrobromide Tablets in Korean Pharmaceutical Codex)

  • 김은정;이진하;박찬호;손경희;김인규;김동섭;사홍기;최후균
    • 약학회지
    • /
    • 제55권4호
    • /
    • pp.324-331
    • /
    • 2011
  • Although the dissolution test can serve as an effective tool for quality control and predictor of in vivo performance, there are a number of drugs with no established dissolution specifications in Korean Pharmaceutical Codex (KPC). Among those commercially available, Piracetam Tablets and Fenoterol hydrobromide Tablets were selected to develop the dissolution testing method. The dissolution condition was determined based on the "Guidelines on Specifications of Dissolution tests for Oral dosage forms" of Korea Food & Drug Administration (KFDA). The dissolution test for Piracetam Tablets was carried out under sink condition with distilled water as dissolution medium, paddle rotation speed at 50 rpm and medium volume of 900 ml. More than 80% of its label claim was released within 30 min. In case of Fenoterol hydrobromide Tablets, distilled water was also found to be suitable to ensure sink condition. The rotation speed of 50 rpm and 900 ml of dissolution medium were used to evaluate the dissolution profile. The dissolution rate of fenoterol hydrobromide was over 90% in 15 min. The HPLC analysis methods were validated in terms of accuracy, precision, specificity, linearity, quantitation limit and range. The results suggested that the analytical methods used are simple and suitable to measure the dissolution rate of piracetam and fenoterol hydrobromide. Therefore, the analysis methods could be utilized in setting dissolution specifications of Piracetam Tablets and Fenoterol hydrobromide Tablets in the revised version of KPC.

염산비퀴딜 캡슐 및 알리벤돌 정의 용출시험에 관한 연구 (Development of the Dissolution Test for Viquidil Hydrochloride Capsules and Alibendol Tablets)

  • 황정분;구은주;고서연;조경철;문현주;조수열;강찬순;손여원;김영옥;손경희;조대현
    • 약학회지
    • /
    • 제54권5호
    • /
    • pp.348-353
    • /
    • 2010
  • The dissolution test method and an analytical procedure by HPLC were developed and validated for viquidil hydrochloride capsules and alibendol tablets. These drugs were not yet characterized by the dissolution specifications in Korean Pharmaceutical Codex. So, with each reference and test drugs, we did the preliminary and standard experiments based on the Korean Pharmacopeia Guideline of dissolution testing for solid oral dosage forms. The dissolution test for viquidil hydrochloride capsules was carried out under sink conditions as follows: dissolution medium water, paddle rotation speed 50 rpm and vessel volume 900 ml. More than 90% of its label amount was released within 30 min in this method. Also the dissolution test for alibendol tablets was carried out under sink conditions as follows: dissolution medium water, paddle rotation speed 100 rpm and vessel volume 900 ml. More than 90% of its label amount was released within 45 min in this method. The dissolution samples were analyzed with a precise and accurate HPLC method. The developed dissolution test showed specificity, linearity, precision and accuracy within the acceptable range. The dissolution testing method described above was adequate for the purpose and may be proposed as a pharmacopeial standard to assess the performance of viquidil hydrochloride capsules and alibendol tablets.

수산나프로닐 캡슐 및 염산트라마돌 캡슐의 용출시험에 관한 연구 (Development of the Dissolution Tests for Nafronyl Oxalate Capsules and Tramadol Hydrochloride Capsules)

  • 황정분;문현주;고서연;장기욱;이규하;손경희;김인규;조대현
    • 약학회지
    • /
    • 제55권5호
    • /
    • pp.411-418
    • /
    • 2011
  • The dissolution test method and an analytical procedure by HPLC were developed and validated for nafronyl oxalate capsules and tramadol hydrochloride capsules. These drugs were not yet characterized by the dissolution specifications in the Korean Pharmaceutical Codex. So, with each reference and test drugs, we did the preliminary and standard experiments based on the Korean Pharmacopeia Guideline of dissolution testing for solid oral dosage forms. The dissolution test for nafronyl oxalate capsules was carried out under sink conditions as follows: dissolution medium phosphate buffer pH 6.8, paddle rotation speed 100 rpm and vessel volume 900 ml. More than 80% of its label amount was released within 30 min in this method. Also the dissolution test for tramadol hydrochloride capsules was carried out under sink conditions as follows: dissolution medium water, paddle rotation speed 50 rpm and vessel volume 900 ml. More than 90% of its label amount was released within 15 min in this method. The dissolution samples were analyzed with a validated HPLC analytical procedure. The analytical methodology showed acceptable values in terms of specificity, linearity, precision and accuracy. The dissolution test methods described above were adequate for the purpose and may be proposed as a pharmacopeial standard to assess the performance of nafronyl oxalate capsules and tramadol hydrochloride capsules. Furthermore, the outcomes of this study were expected to help create an environment where safe and high quality drugs would be distributed on the domestic market making contributions to advancing public health.

Prediction of the human in vivo antiplatelet effect of S- and R-indobufen using population pharmacodynamic modeling and simulation based on in vitro platelet aggregation test

  • Noh, Yook-Hwan;Han, Sungpil;Choe, Sangmin;Jung, Jin-Ah;Jung, Jin-Ah;Hwang, Ae-Kyung;Lim, Hyeong-Seok
    • Translational and Clinical Pharmacology
    • /
    • 제26권4호
    • /
    • pp.160-165
    • /
    • 2018
  • Indobufen ($Ibustrin^{(R)}$), a reversible inhibitor of platelet aggregation, exists in two enantiomeric forms in 1:1 ratio. Here, we characterized the anti-platelet effect of S- and R-indobufen using response surface modeling using $NONMEM^{(R)}$ and predicted the therapeutic doses exerting the maximal efficacy of each enantioselective S- and R-indobufen formulation. S- and R-indobufen were added individually or together to 24 plasma samples from drug-naïve healthy subjects, generating 892 samples containing randomly selected concentrations of the drugs of 0-128 mg/L. Collagen-induced platelet aggregation in platelet-rich plasma was determined using a Chrono-log Lumi-Aggregometer. Inhibitory sigmoid $I_{max}$ model adequately described the anti-platelet effect. The S-form was more potent, whereas the R-form showed less inter-individual variation. No significant interaction was observed between the two enantiomers. The anti-platelet effect of multiple treatments with 200 mg indobufen twice daily doses was predicted in the simulation study, and the effect of S- or R-indobufen alone at various doses was predicted to define optimal dosing regimen for each enantiomer. Simulation study predicted that 200 mg twice daily administration of S-indobufen alone will produce more treatment effect than S-and R-mixture formulation. S-indobufen produced treatment effect at lower concentration than R-indobufen. However, inter-individual variation of the pharmacodynamic response was smaller in R-indobufen. The present study suggests the optimal doses of R-and S-enantioselective indobufen formulations in terms of treatment efficacy for patients with thromboembolic problems. The proposed methodology in this study can be applied to the develop novel enantio-selective drugs more efficiently.

다공성의 캐리어를 이용한 티카그렐러 함유 고형의 자가 나노유화 약물전달시스템 개발 (Development of Solid Self-nanoemulsifying Drug Delivery Systems of Ticagrelor Using Porous Carriers)

  • 최형주;김경수
    • 생명과학회지
    • /
    • 제31권5호
    • /
    • pp.502-510
    • /
    • 2021
  • 자가 나노유화 약물전달시스템(SNEDDS)은 오일, 계면활성제, 공계면활성제의 균질한 혼합물로서 가벼운 교반에 의해도 에멀전 형성이 가능하고 분산 시 200 nm 이하 범위의 입자 크기를 갖는 나노 에멀전을 형성하는 약물 수송체를 말한다. SNEDDS는 난용성이며 생체이용률이 낮은 소수성약물의 흡수율을 높일 수 있는 뛰어난 가용화 방법으로 알려져 있다. 본 연구에서는 난용성인 티카그렐러에 대한 용해도가 높은 유상으로 MCT oil과, 계면활성제로 Tween 80, 공계면활성제로 Labrafil M1944CS를 사용하여 SNEDDS를 개발하고, 분무건조기술을 이용하여 다양한 다공성의 캐리어에 흡착시켜 고형의 SNEDDS를 제조하였다. 제조된 고형의 SNEDDS에 대하여 물리화학적 특성 및 분말특성을 평가한 후 용출시험을 진행하였다. 본 연구를 통해 얻어진 다공성의 캐리어에 흡착시켜 만들어진 다양한 고형 SNEDDS에서 티카그렐러의 결정형은 무정형으로 변환된 것을 확인할 수 있었다. 또한 제조된 고형의 SNEDDS 조성물들은 모두 원료에 비하여 우수한 용출양상을 나타내는 것을 확인할 수 있었다. 특히 이산화규소를 통해 얻어진 고형의 SNEDDS 조성물의 입자크기와 다분산지수가 제일 작았으며 흐름성과 압축성도 제일 우수하였다. 따라서 이산화규소를 통해 얻어진 고형의 SNEDDS 조성물은 난용성인 티카그렐러의 경구 고형제제화 연구에 적합한 약물 전달 시스템인 것을 확인할 수 있었다.

오령산 정제 개발 및 항염증 효과 (Effect of Anti-inflammation on Oryeong-san Formulation for Mix Extract Tablet)

  • 김세진;임현희;남원희;손수미;최혜민;김명진;김정옥;이화동
    • 동의생리병리학회지
    • /
    • 제34권6호
    • /
    • pp.348-354
    • /
    • 2020
  • Oryeong-san (ORS) is a traditional Korean herbal medicine widely used for renal associated diseases, composed of five medicine herbs; Atractylodes japonica Koidzumi, Cinnamomum cassia Presl, Polyporus umbellatus Fries, Poria cocos Wolf and Alisma orientale Juzepzuk. We studied to improve the convenience of intake and portability by developing modernized dosage forms, and examined the effect on anti-inflammation of ORS. In order to develop the tablet formulation of ORS (ORS-F), the tablets were evaluated on the basis of physical characteristics include diameter, thickness, weight variation, hardness, friability and disintegration. To analyze the marker components of ORS-F, eight index markers from five herbal medicines were chosen. And the method using high performance liquid chromatography (HPLC) with diode-array detector method was established for the simultaneous analysis. The biological activities were examined the effect of ORS-F on pro-inflammation mediated by LPS-stimulation. The production of nitric oxide (NO) and cytokines were determined by reacting cultured medium with griess reagent and enzyme-linked immunosorbent assay (ELISA). The expression of cyclooxygenase-2 (COX-2) and inducible NO synthase (iNOS) were investigated by Western blot and RT-PCR. The anti-oxidant activities of OJS-F increased markedly, in a dose-dependent manner. and, The total phenolic compound and flavonoids contents of OJS-F were 10.20±0.09 ㎍/㎎ and 12.86±0.86 ㎍/㎎. OJS-F which is LPS has diminished in the LPS-induced release of inflammatory mediators (NO, iNOS, COX2 and PGE2) and pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) from the RAW264.7 macrophages. Therefore, the developed formulation for tablet of ORS-F provide efficiency and usability, and indicated effect of anti-inflammation.

속방형 및 용출조절형 비타민 C 정제의 용출 특성 비교 분석 (Comparative Study of Dissolution Properties of Immediate-release and Controlled-release Type Vitamin C Tablets)

  • 양효진;류나희;양주홍;홍선호;이연경;조양희
    • 한국식품위생안전성학회지
    • /
    • 제37권2호
    • /
    • pp.114-120
    • /
    • 2022
  • 본 연구에서는 체내에서 비타민 C의 지속성을 나타내기 위해 성분의 용출을 조절하는 기술이 적용된 용출조절형 비타민 C 제품과 일반적인 속방형 비타민 C 제품의 비교용출 실험을 진행하여, 일반적인 속방형 제품과 용출조절형 제품 간의 용출 양태를 비교분석 하였다. 비타민 C 정제들의 용출률을 확인하기 위해 '대한약전(제2020-88호)', '경구용의약품의 용출규격 설정 가이드라인'의 용출시험법, '건강기능식품의 기준 및 규격 고시(제2020-63호)'에 근거한 HPLC 함량시험을 수행하여 시간별 용출률을 분석하였다. 분석 결과 속방형 비타민 C 제품은 45분 이후 100% 용출이 이루어진 반면 용출조절형 비타민 C 제품은 480분(8시간) 이후에 100% 용출이 나타났으며, 용출조절형 비타민 C 제품의 60분에서의 용출률이 속방형 비타민 C 제품에 비해 더 느리게 나타나는 것을 확인하였다. 이러한 결과를 바탕으로 비타민 C를 주성분으로 한 용출조절형 정제의 개발 및 용출분석이 가능함을 확인하였다.

비누화 및 액체크로마토그래프를 활용한 고상 건강기능식품 중 라이코펜 분석법 개발 (A simple method to determine lycopene in solid supplementary food preparations using saponification and liquid chromatography)

  • 김영민;신예빈;권민경;김진환;김지성;이동규;강명주;최용석
    • 분석과학
    • /
    • 제36권3호
    • /
    • pp.105-112
    • /
    • 2023
  • 라이코펜은 카로티노이드의 일종으로 심혈관계 위험인자, 혈중지질, 혈압 등을 낮추는 효과를 가지는 것으로 알려져 있어, 액상 내용물이 충진된 연질캡슐, 고상 내용물이 충진된 경질캡슐을 포함하는 다양한 제형의 라이코펜 건강기능식품이 유통되고 있다. 그러나, 최근 본 연구진은 현 건강기능식품공전 중 라이코펜 시험법의 고상 건강기능식품 적용에 한계가 있음을 확인하였다. 따라서, 본 논문에 비누화 반응 및 액체크로마토그래프에 기반한 신규 고상 건강기능식품 중 라이코펜 시험법의 개발을 보고하는 바이다. 신규 개발 시험법은 식품의약품안전평가원 가이드라인에 의거하여 밸리데이션 되었고, 모든 항목 결과가 가이드라인 기준을 만족함(특이성, 직선성 r2≥0.991, 정량한계 0.0149 mg/mL, 정확도(회수율) 92.70~97.18 %, 반복성(회수율의 상대표준편차) 0.85~1.59 %, 재현성(실험실 간 회수율의 상대표준편차) 3.70 %)을 확인하였다. 또한 인증표준물질을 활용한 적용성 평가에서도 높은 정확도(98.81~101.59 %)가 관찰되어, 신규 시험법의 개발이 성공적이었음을 재확인하였다. 따라서, 신규 개발 시험법은 향후 고상 라이코펜 건강기능식품 관리에 활용되어 국내 건강식품안전관리에 기여할 수 있을 것으로 판단된다.

안정화제로 사용된 황산칼슘비료의 물리적 형태에 따른 토양 비소 및 수은의 안정화와 식물체 전이특성 (Transfer of Arsenic and Mercury from Stabilized Farmland Soil to Lettuce using Calcium Sulfate Fertilizer with Different Physical Properties as a Stabilizing Agent)

  • 고일하;권요셉;이민현;김정은;박소영;고주인;지원현
    • 자원환경지질
    • /
    • 제56권5호
    • /
    • pp.619-628
    • /
    • 2023
  • 본 연구에서는 토양 내 비소 및 수은의 안정화제로 황산칼슘비료의 적용 가능성을 검토하였다. 아울러 황산칼슘비료의 물리적 특성(입자상, 미분상, 용액상)에 따른 비소 및 수은의 안정화 특성을 상추 재배 포트실험으로 비교?검토하였다. 34일 간의 상추재배를 통해 확인한 비소 및 수은의 전이감소 효과는 대체적으로 70% 이상인 것으로 나타나 안정화제로서의 적용성을 확인하였다. 다만, 용액상 안정화제 처리조건에서 성장한 상추의 생체량은 대조구의 46% 수준으로 가장 낮았는데, 이는 안정화제로부터 유래된 영양물질의 유효도가 극단적으로 높아 오히려 식물체 성장을 저해한 것으로 판단되었다. 토양 내 비소 및 수은의 분획특성 확인결과 수은에서만 존재형태의 변화가 크게 나타났다. 수은은 안정화 처리된 토양에서 원소수은의 감소와 잔류형/황화물 형태의 증가가 확인되었는데, 이러한 경향은 용액상 > 미분상 > 입자상의 순서로 나타났다. 본 연구를 통해 대형 교반장비의 진입이 어려운 농경지에서는 용액상 처리제의 살포만으로 안정화 효과를 얻을 수 있음을 확인하였다. 다만, 높은 영양물질 유효도로 인해 염해토양의 특성을 보일 수 있으므로, 투여량 조절을 통해 농작물 위해를 사전 제어할 필요가 있다.